Lutalyse Injection Patent Expiration

Exclusivity Information

Lutalyse Injection holds 1 exclusivity out of which 1 has expired. Details of Lutalyse Injection's exclusivity codes and their expiration dates are given below.

Drug Exclusivity Drug Exclusivity Expiration
NCI Jun 09, 2017

About Lutalyse Injection

Lutalyse Injection is a drug owned by ZOETIS INC. Lutalyse Injection uses Dinoprost Tromethamine as the active ingredient.

Active Ingredient:

Lutalyse Injection uses Dinoprost Tromethamine as the active ingredient. Check out other Drugs and Companies using Dinoprost Tromethamine ingredient.